Rosebud Biosciences Analysis
What is Rosebud Biosciences?
Rosebud Biosciences develops therapies for rare genetic diseases in children using organoids that model human development and replicate genetic mutations.
Founded
2020
Company Stage
Pre-Seed
YC Batch
W22
Product Features & Capabilities
- Organoid platform, targeted therapies for rare genetic diseases, cardiac organoids, hepatic organoids, neural organoids, kidney organoids, drug screening using human induced pluripotent stem cells (hiPSCs), mutation-specific organoid models.
Who are the founders of Rosebud Biosciences
KW
Kitch Wilson
CEO
EL
Evan Lyall
CTO
Investors
- Y Combinator
- National Science Foundation (NSF)
- 10X Capital
- Arvantis Group
- Gaingels
